NLS Pharmaceutics Ltd. Gains 44%
Tue, Nov 01, 2022 at 07:27 PM
NLS Pharmaceutics Ltd. (NLSP:NASDAQ) jumped higher at $0.74, representing a gain of 44%. On Tue, Nov 01, 2022, NLSP:NASDAQ hit a New 2-Week High of $0.74. The stock got featured on our News Catalysts scanner on Wed, Oct 05, 2022 at 06:52 PM in the 'INVESTOR UPDATE' category. From Tue, Oct 18, 2022, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Nov 01, 2022 at $0.93 with a volume of 16M+.
About NLS Pharmaceutics Ltd. (NLSP:NASDAQ)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders.
Top 10 Gainers:
- Abiomed, Inc. (ABMD:NASDAQ), 49.88%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 46.63%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 44%
- Ucommune International Ltd (UK:NASDAQ), 34.65%
- Safe-T Group Ltd (SFET:NASDAQ), 30.7%
- Aravive, Inc. (ARAV:NASDAQ), 30.53%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 25.13%
- IDEX Biometrics ASA (IDBA:NASDAQ), 23.01%
- Harsco Corporation (HSC:NYSE), 22.5%